Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion

Fig. 4

Wild type EpCAM physically interacts with CTSL. a MDA-MB-468 cell lysates were immunoprecipitated with EpCAM (clone C-10) or control (IgG) antibody as described in methods section. EpCAM immunoprecipitation pulls down CTSL. b Cell lysates were immunoprecipitated with CTSL or control (IgG) antibody. CTSL immunoprecipitation pulls down EpCAM. Full length blots are presented in Supplementary Fig. 5

Back to article page